Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myomo (MYO) EBITDA (2016 - 2025)

Myomo's EBITDA history spans 10 years, with the latest figure at -$3.5 million for Q3 2025.

  • For Q3 2025, EBITDA fell 267.34% year-over-year to -$3.5 million; the TTM value through Sep 2025 reached -$11.9 million, down 41.44%, while the annual FY2024 figure was -$6.2 million, 24.6% up from the prior year.
  • EBITDA reached -$3.5 million in Q3 2025 per MYO's latest filing, up from -$4.6 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$245314.0 in Q4 2024 to a low of -$4.6 million in Q2 2025.
  • Average EBITDA over 5 years is -$2.5 million, with a median of -$2.7 million recorded in 2023.
  • Peak YoY movement for EBITDA: soared 89.92% in 2024, then crashed 311.66% in 2025.
  • A 5-year view of EBITDA shows it stood at -$2.7 million in 2021, then grew by 17.61% to -$2.2 million in 2022, then dropped by 9.14% to -$2.4 million in 2023, then skyrocketed by 89.92% to -$245314.0 in 2024, then crashed by 1333.88% to -$3.5 million in 2025.
  • Per Business Quant, the three most recent readings for MYO's EBITDA are -$3.5 million (Q3 2025), -$4.6 million (Q2 2025), and -$3.5 million (Q1 2025).